Sign Up to like & get
recommendations!
0
Published in 2025 at "Advanced science"
DOI: 10.1002/advs.202512139
Abstract: Peptide-based cancer vaccines offer favorable safety and stability profiles but are limited by rapid clearance and poor immunogenicity. Here, a ≈20 nm solid self-emulsifying (SSE) nanovaccine platform that co-delivers peptide antigens and an oligonucleotide adjuvant containing…
read more here.
Keywords:
designer solid;
cells cells;
dendritic cells;
solid self ... See more keywords